Testing a two-in-one vaccine for hand, foot, and mouth disease
Part of Infections clinical trials.
This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 months and 59 years old.
- You have not received a vaccine targeting EV71 or hand, foot, and mouth disease before.
- You have no serious allergies or medical conditions that could interfere with the vaccine.
- You are not pregnant or breastfeeding, and if applicable, you agree to use birth control for 12 months.
- You have no major health issues, such as bleeding disorders, immune system problems, or chronic diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This study tests three batches of an EV71 vaccine (which prevents hand, foot, and mouth disease) to see if they work the same. Your child would receive two doses, several weeks apart, and have blood tests to check their immune response.
This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.
This trial tests whether breathing in a medication called pegylated interferon helps children with mild hand, foot, and mouth disease recover faster. It is for children ages 1 to 6 who have had symptoms like fever or rash for 3 days or less.
Hear when a new Hand, Foot and Mouth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.